In a report released on January 10, Conor McNamara from RBC Capital maintained a Buy rating on QuidelOrtho (QDEL – Research Report), with a ...
SAN DIEGO, December 31, 2024--QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a global provider of innovative in-vitro diagnostic technologies designed for point-of-care settings ...
QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and ...
SAN DIEGO--(BUSINESS WIRE)-- QuidelOrtho Corporation (Nasdaq ... reliable diagnostics when and where they are needed – from home to hospital, lab to clinic. So that patients, clinicians and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback